PCI Pharma Services Opens Three New Facilities in Rockford, Aiming to Create 650 Jobs

Rockford, IL, September 22, 2026 —

PCI Pharma Services has announced the opening of three new facilities located in Rockford. The expansion is expected to generate significant employment opportunities in the region, with projections indicating the creation of up to 650 jobs.

The company, a global contract development and manufacturing organization (CDMO), has established these new sites as part of its strategic growth initiatives. While the specific nature and capacity of each of the three facilities were not detailed, the expansion signals a substantial investment in the Rockford area’s pharmaceutical and biotechnology sectors.

The addition of these facilities is anticipated to bolster the local economy by providing a range of employment positions. The exact timeline for the full realization of the 650 job openings and the types of roles being created have not been publicly specified. The company’s move into these new locations represents a notable development for the industrial landscape of Rockford.

PCI Pharma Services provides a comprehensive suite of services to the pharmaceutical and biotechnology industries, including drug development, manufacturing, and sterile drug product and clinical trial services. The expansion in Rockford is expected to enhance the company’s ability to serve its clients and meet growing market demands.

Further details regarding the operational scope and specific contributions of these new facilities to PCI Pharma Services’ global network are anticipated to be released in the future.

Story summarized from the original created by Google News on news.google.com, see more information here.